Products
3579 products
Page:1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
| Code | Description | Unit |
|---|---|---|
| USP-1117110 | Chloropropyl Vanillin - (4-(3-Chloropropoxy)-3-methoxybenzaldehyde) | 25 mg |
| USP-1133842 | L-Citrulline | 200 mg |
| USP-1148089 | Collagenase I (COLD SHIPMENT REQUIRED) | 2 x 0.5 mL |
| USP-1148090 | Collagenase II (COLD SHIPMENT REQUIRED) | 2 x 0.5 mL |
| USP-1150320 | Creatine - ((S)-2-Amino-5-ureidopentanoic acid) | 200 mg |
| USP-1164222 | Darifenacin Peak ID Mixture - (A mixture consisting of Darifenacin Hydrobromide (99%), Dealkyl darifenacin (0.3%), Ketodarifenacin (0.2%), and 7-Bromo darifenacin (0.3%)) | 25 mg |
| USP-1235059 | Emodin - (1,3,8-trihydroxy-6-methylanthracene-9,10-dione) | 30 mg |
| USP-1336249 | Iloperidone | 200 mg |
| USP-1336250 | Iloperidone Related Compound A - ([4'-(3-Chloropropoxy)-3'-methoxy]acetophenone) | 20 mg |
| USP-1369689 | Lonicera Japonica Flower Dry Extract - A plant extract from the dried flowers of Lonicera Japonica containing six caffeoylquinic acids, three iridoids and two flavonoids | 500 mg |
| USP-1369703 | Lonicera Macranthoides Flower Dry Extract - (Mixture, with identified compendial components Dipsacoside B, Macranthoidin A and Macranthoidin B) | 500 mg |
| USP-1370837 | Luteolin 7-O-Glucoside- (2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-4H-chromen-7-yl beta-D-glucopyranoside) | 30 mg |
| USP-1478163 | Oleuropein - (Methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate) | 25 mg |
| USP-1478265 | Olive Leaf Dry Extract - Mixture containing about 20% w/w of Oleuropein | 500 mg |
| USP-1569315 | Pimobendan - (6-[2-(4-Methoxyphenyl)-1H-benzimidazol-5-yl]-5-methyl-4,5-dihydropyridazin-3(2H)-one) | 100 mg |
| USP-1569337 | Pimobendan Related Compound B - (N-[2-Amino-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl]-4-methoxybenzamide) | 15 mg |
| USP-1589029 | Pyroglutamic Acid - ((S)-5-Oxopyrrolidine-2-carboxylic acid) | 30 mg |
| USP-1611117 | Secoxyloganin - ([(2S,3R,4S)-2-(beta-D-Glucopyranosyloxy)-5-(methoxycarbonyl)-3-vinyl-3,4-dihydro-2H-pyran-4-yl]acetic acid) | 50 mg |
| USP-1443825 | Skim Milk Powder | each |
| USP-1443883 | Skim Milk Powder with Melamine - Level D | 20 g |
| USP-1619028 | Spironolactone Related Compound B - ((2'R)-7alpha-(Acetylthio)-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione) | 30 mg |
| USP-1629019 | Sulfamethazine Related Compound A - (4-Amino-N-carbamimidoylbenzenesulfonamide-, monohydrate) | 100 mg |
| USP-1629021 | Sulfamethazine Related Compound B - (Mixture containing about 49% of 4-Amino-2-chloro-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide and about 48% of 4-Amino-3-chloro-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide) | 50 mg |
| USP-1711455 | Verbascoside - (2-(3,4-Dihydroxyphenyl)ethyl 3-O-(6-deoxy-alpha-L-mannopyranosyl)-4-O-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-Beta-D-glucopyranoside) | 15 mg |
| USP-1724703 | Zinc Acetate | 50 mg |
| USP-1011890 | Advantame Acid (20 mg) - (N-[N-[3-(3-hydroxy-4-methoxyphenyl)propyl]aspartyl]phenylalanine) - Mixture of advantame acid and its sodium salt | 20 mg |
| USP-1096529 | Carglumic Acid Related Compound B (30 mg) - ((S)-2,7-dioxo-1,3-diazepane-4-carboxylic acid) | 30 mg |
| USP-1140258 | Clomipramine Related Compound A (25 mg) - (N1-[3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]-N1,N3,N3-trimethylpropane-1,3-diamine dihydrochloride | 25 mg |
| USP-1162545 | Dalfampridine Related Compound A (25 mg) - (4-Aminopyridine 1-oxide) | 25 mg |
| USP-1162556 | Dalfampridine Related Compound B (50 mg) - (3,5-Dibromopyridin-4-amine) | 50 mg |
| USP-1548098 | This item has been discontinued - Pomegranate Juice Concentrate (5 x 1 mL) | 5 x 1 mL |
| USP-1559618 | Pregabalin CV (200 mg) | 200 mg |
| USP-1096021 | Carbinoxamine Related Compound B (25 mg) - ((4-Chlorophenyl)(pyridin-2-yl)methanol) | 25 mg |
| USP-1569326 | Pimobendan Related Compound A (15 mg) - (4-[2-(4-Methoxyphenyl)-1H-benzimidazol-5-yl]-3-methyl-4-oxobutanoic acid) | 15 mg |
| USP-1547153 | Polygonum multiflorum Root Dry Extract (200 mg) | 200 mg |
| USP-1651654 | 2,3,5,4'-Tetrahydroxystilbene-2-O-Beta-D-Glucoside (50 mg) - ((E)-2,4-dihydroxy-6-(4-hydroxystyryl)phenyl beta-D-glucopyranoside) | 50 mg |
| USP-1096019 | Carbinoxamine Related Compound A (25 mg) - ((4-Chlorophenyl)(pyridin-2-yl)methanone) | 25 mg |
| USP-1043149 | Ascorbyl Stearate | 500 mg |
| USP-1171273 | Deoxycholic Acid | 100 mg |
| USP-1282591 | Foeniculin - ((E)-1-[(3-Methylbut-2-en-1-yl)oxy]-4-(prop-1-en-1-yl)benzene) | 4 x 50 mg |
| USP-1463472 | Nilutamide | 200 mg |
| USP-1724758 | Zinc Stearate - (Mixture of zinc stearate and zinc palmitate) | 200 mg |
| USP-1162567 | Dalfampridine Related Compound C (25 mg) - (1,3-Di(pyridin-4-yl)urea) | 25 mg |
| USP-1164211 | Darifenacin Chiral Peak ID Mixture (25 mg) (A mixture containing darifenacin hydrobromide, (S)-2-{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide [133099-07-7], and about 1% of darifenacin R-isomer, (R)-2-{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide) [1092800-15-1] | 25 mg |
| USP-1164200 | Darifenacin Hydrobromide (150 mg) - ((S)-2-{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide) | 150 mg |
| USP-1294150 | Gluconolactone (100 mg) - (Glucono delta-lactone) | 100 mg |
| USP-1478141 | Oleanolic Acid (15 mg) ((3beta)-3-hydroxyolean-12-en-28-oic acid) | 15 mg |
| USP-1559629 | Pregabalin Related Compound A (25 mg) - ((R)-3-(Aminomethyl)-5-methylhexanoic acid) | 25 mg |
| USP-1559647 | Pregabalin Related Compound C (25 mg) - (4-Isobutylpyrrolidin-2-one) | 25 mg |
| USP-1559709 | Prekallikrein Activator (22.5 IU) - This material contains 45 IU/mL of PKA activity in 20% Albumin Human when reconstituted in 0.5 mL. | 22.5 IU |
| USP-1348601 | Red Clover Aerial Parts Isoflavone Aglycones Dry Extract | each |
| USP-1096860 | Carnauba Wax (200 mg) | 200 mg |
| USP-1096826 | Castor Oil (3 x 100 mg) (Mixture containing about 92% of Triricinolein) | 3 x 100 mg |
| USP-1098093 | Ceftiofur System Suitability Mixture (50 mg) (Mixture of about 93% of ceftiofur (CAS: 80370-57-6) and total of about 2% of ceftiofur delta-3 isomer (CAS: 120962-17-6) and ceftiofur E-isomer (CAS: 120882-20-4)) | 50 mg |
| USP-1470026 | Norethindrone Related Compound B CIII (30 mg) (Estr-4-ene-3,17-dione) | 30 mg |
| USP-1496959 | Paraldehyde (3 x 1.5 mL) | 3 x 1.2 mL |
| USP-1548010 | Poly(ethylene-vinyl acetate) (1 g) | 1 g |
| USP-1602105 | trans-Resveratrol (100 mg) | 100 mg |
| USP-1002811 | Acetaldehyde | 3 x 1,1 mL |
| USP-1096032 | Carbinoxamine Related Compound C - (N,N-Dimethyl-2-[phenyl(pyridin-2-yl)methoxy]ethan-1-amine oxalate) | 25 mg |
| USP-1133897 | Cinnamaldehyde ((2E)-3-Phenylacrylaldehyde) | 3 x 100 mg |
| USP-1133900 | Cinnamomum Cassia Twig Powder | 5 g |
| USP-1236663 | Epicoprostanol ((3alpha,5beta)-Cholestan-3-ol) | 200 mg |
| USP-1269009 | [Met(O)14]-Exenatide | 1 mg |
| USP-1268998 | [Glu13]-Exenatide | 1 mg |
| USP-1430917 | Methyl 12-Hydroxystearate | 200 mg |
| USP-1269045 | [N-Acetyl-His1]-Exenatide | 1 mg |
| USP-1131858 | Cholestanol | 200 mg |
| USP-1372344 | Polyamide 6 (Poly(hexano-6-lactam)) | 1 g |
| USP-1021292 | Aminotriazinone - (3-Amino-1,2,4-triazin-5(2H)-one) | 300 mg |
| USP-1270480 | Fingolimod Hydrochloride | 300 mg |
| USP-1270526 | Fingolimod System Suitability Mixture | 40 mg |
| USP-1544858 | Plant Stanol Esters | 10 x 100 mg |
| USP-1724474 | Ziprasidone Related Compound F - (Sodium 2-(2-amino-5-{2-[4-(benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-4-chlorophenyl)acetate monohydrate) | 15 mg |
| USP-2400001 | 2017 USP40-NF35 Print Subscription | each |
| USP-1076192 | BSA for Protein Quantitation | 5 x 1 mL |
| USP-1031616 | Amoxicillin Related Compound H - ((R)-2-(4-hydroxyphenyl)-2-pivalamidoacetic acid) | 15 mg |
| USP-1269105 | Exenatide | 2,73 mg |
| USP-1288452 | Gatifloxacin Related Compound E - (1-Cyclopropyl-6-fluoro-8-methoxy-7-(2-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monohydrochloride) | 15 mg |